Taha Alrifai, MD
Hematology & Oncology Physician · Park Ridge, IL
Taha Alrifai, MD is a hematology & oncology physician with a practice address in Park Ridge, Illinois, and NPI 1023463932, issued on Apr 28, 2016. Check the license (Illinois 036147384, as entered in NPPES) on the Illinois Department of Financial and Professional Regulation; the Medicare figures below come from public CMS files.
- Name
- Taha Alrifai
- Credential
- MD
- Primary taxonomy
- Hematology & Oncology Physician 207RH0003X
- License number
- 036147384 IL
Self-reported in NPPES; status is on the state search - Practice location
- 1700 Luther LN Ste 2200, Park Ridge, IL 60068
- Phone
- (847) 268-8200
- Enumerated
- Apr 28, 2016
- Record last updated
- Aug 30, 2024
- Fax
- (847) 318-2905
- Medicare enrollment
- Enrolled (PECOS I20190709002118); accepts Medicare assignment
- Telehealth
- Offers telehealth (CMS)
- Entity
- Type 1 · individual
8 nearest hematology & oncology physician records → All 666 in Illinois → Look up another NPI →
Also registered at 1700 Luther LN Ste 2200
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Sabree Abedrabo, MDHematology & Oncology Physician1790344471
- Harrah Chiang, DOHematology & Oncology Physician1467102640
- Ari Hakimian, DOHematology & Oncology Physician1447888276
- Christie Hancock, M.D.Hematology & Oncology Physician1083050413
- Michael JacobsHematology & Oncology Physician1558854745
- Jason Macklis, M.D.Hematology & Oncology Physician1003136458
Verify Taha Alrifai in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersIllinois Department of Financial and Professional Regulation
Search for license 036147384Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
35% fewer Medicare Part D claims than the average hematology & oncology physician in 2024
574 Medicare Part D claims for 142 beneficiaries, against an average of 877 among the 10,784 providers of this specialty who prescribed in Part D. Brand-name drugs were 39% of claims. 17 claims were for opioids.
Most prescribed
- Eliquis77 claims
- Acyclovir46 claims
- Prednisone29 claims
- Allopurinol28 claims
- Hydroxyurea28 claims
- Xarelto28 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Bills Medicare through one group practice
- Advocate Health And Hospitals CorporationPark Ridge, IL
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Taha Alrifai among 666 hematology & oncology physician records in Illinois
Taha Alrifai, MD is one of 666 hematology & oncology physician records with a practice address in Illinois. 84% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2016, is newer than 76% of them.
- NPI issued2016 · 76% of these records are older, 20% newer
- In a Medicare fileYes · 84% of these records are
- In the CMS Doctors and Clinicians fileYes · 69% of these records are
- Graduated2014 · median 2003 among the 461 with a school on file
- Record last updated2024 · 49% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RH0003X and a Illinois practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Hematology & Oncology Physician providers in Illinois
There are 666 hematology & oncology physician records in Illinois.
All 666 in Illinois → Every provider in Park Ridge → Hematology & Oncology Physician nationwide →
The 8 hematology & oncology physician records with the nearest ZIP codes
- Jacob Bitran, M.D.Park Ridge, IL 600681407815822
- Shams Bufalino, M.D.Park Ridge, IL 600681831488741
- Angel Galvez, M.D.Park Ridge, IL 600681144280835
- Sigrun Hallmeyer, MDPark Ridge, IL 600681164481412
- Christie Hancock, M.D.Park Ridge, IL 600681083050413
- Arthur Hooberman, M.D.Park Ridge, IL 600681124088489
- Edward James, M.D.,Park Ridge, IL 600681548442007
- Pamela Kaiser, M.D.Park Ridge, IL 600681184684821
Common questions
What is Taha Alrifai, MD's NPI number?
Taha Alrifai, MD's National Provider Identifier (NPI) is 1023463932, issued on Apr 28, 2016. An NPI identifies a provider in billing; it is not a license.
Where is Taha Alrifai, MD located?
The NPPES record lists a practice address at 1700 Luther LN Ste 2200, Park Ridge, IL, 60068. Phone: (847) 268-8200. Providers update this record themselves, so call before visiting.
How can I verify Taha Alrifai, MD's license?
NPPES lists Illinois license number 036147384, as entered by the provider. Search the Illinois Department of Financial and Professional Regulation at https://idfpr.illinois.gov/checklicense.html. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Taha Alrifai, MD prescribe under Medicare Part D?
In 2024, Taha Alrifai, MD had 574 Medicare Part D claims for 142 beneficiaries; the average among hematology & oncology physician prescribers was 877. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.